These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25633103)

  • 21. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
    Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
    Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer.
    Kalimutho M; Del Vecchio Blanco G; Di Cecilia S; Sileri P; Cretella M; Pallone F; Federici G; Bernardini S
    J Gastroenterol; 2011 Dec; 46(12):1391-402. PubMed ID: 21863218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
    Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
    Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
    Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.
    Fesler A; Jiang J; Zhai H; Ju J
    Mol Diagn Ther; 2014 Jun; 18(3):303-8. PubMed ID: 24566942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA as a Biomarker for the Early Detection of Colorectal Cancer.
    Coleman D; Kuwada S
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive molecular biomarkers for the detection of colorectal cancer.
    Kim HJ; Yu MH; Kim H; Byun J; Lee C
    BMB Rep; 2008 Oct; 41(10):685-92. PubMed ID: 18959813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
    Ferracin M; Lupini L; Mangolini A; Negrini M
    Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Circulating MicroRNAs as Biomarkers of Colorectal Cancer].
    Umemura T; Kuroki C
    Rinsho Byori; 2015 Mar; 63(3):336-46. PubMed ID: 26524857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA signatures: novel biomarker for colorectal cancer?
    Luo X; Burwinkel B; Tao S; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
    Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Huang X; Zhu X; Yu Y; Zhu W; Jin L; Zhang X; Li S; Zou P; Xie C; Cui R
    Cancer Lett; 2021 Mar; 501():66-82. PubMed ID: 33385486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.
    Tsang AH; Cheng KH; Wong AS; Ng SS; Ma BB; Chan CM; Tsui NB; Chan LW; Yung BY; Wong SC
    World J Gastroenterol; 2014 Apr; 20(14):3847-57. PubMed ID: 24744577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.
    Tovar-Camargo OA; Toden S; Goel A
    Expert Rev Mol Diagn; 2016; 16(5):553-67. PubMed ID: 26892862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor markers and colorectal cancer: utility in management.
    Crawford NP; Colliver DW; Galandiuk S
    J Surg Oncol; 2003 Dec; 84(4):239-48. PubMed ID: 14756436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.